These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9212981)

  • 1. Anti Candida activity of induced transferrin in mice immunized with inactivated Candida albicans.
    Watanabe T; Tanaka H; Nakao N; Mikami T; Suzuki M; Matsumoto T
    Biol Pharm Bull; 1997 Jun; 20(6):637-40. PubMed ID: 9212981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apotransferrin has a second mechanism for anticandidal activity through binding of Candida albicans.
    Han Y
    Arch Pharm Res; 2014 Feb; 37(2):270-5. PubMed ID: 24155020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.
    Tansho S; Ab S; Mizutani S; Ono Y; Takesako K; Yamaguchi H
    Microbiol Immunol; 2002; 46(5):307-11. PubMed ID: 12139389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of ferroproteins by Candida albicans during candidastasis by apotransferrin.
    Han Y
    Arch Pharm Res; 2005 Aug; 28(8):963-9. PubMed ID: 16178424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
    Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
    Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.
    Mizutani S; Endo M; Ino-Ue T; Kurasawa M; Uno Y; Saito H; Kato I; Takesako K
    Antimicrob Agents Chemother; 2000 Feb; 44(2):243-7. PubMed ID: 10639344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of iron on fluconazole activity against Candida albicans in presence of human serum or monocyte-derived macrophages.
    Minn Y; Brummer E; Stevens DA
    Mycopathologia; 1997; 138(1):29-35. PubMed ID: 9404022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
    Tavares D; Ferreira P; Arala-Chaves M
    Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans can utilize siderophore during candidastasis caused by apotransferrin.
    Lee JH; Han Y
    Arch Pharm Res; 2006 Mar; 29(3):249-55. PubMed ID: 16596999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of transferrin.
    Shiraishi A; Arai T
    Sabouraudia; 1979 Mar; 17(1):79-83. PubMed ID: 375440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced clearance of Candida albicans from lung after intratracheal immunization.
    Lal S; Mitsuyama M; Amako K; Nomoto K
    J Clin Lab Immunol; 1986 Sep; 21(1):23-30. PubMed ID: 3543372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against systemic infections with various Candida species elicited by vaccination with Candida albicans ribosomes.
    Segal E; Nussbaum S; Barr-Nea L
    Sabouraudia; 1985 Aug; 23(4):275-85. PubMed ID: 3901330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans, Cryptococcus neoformans or Aspergillus fumigatus induces an antifungal activity in mouse serum, which is different from transferrin.
    OKAZAKI K; ASAKURA M; SUGIMOTO N; HINENOYA A; YAMASAKI S
    J Vet Med Sci; 2009 Nov; 71(11):1459-64. PubMed ID: 19959896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental candidiasis associated with liver injury. Role of transferrin.
    Abe F; Katoh T; Inaba H; Hotchi M
    Mycopathologia; 1988 Oct; 104(1):3-6. PubMed ID: 2975353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.
    Levy R; Segal E; Eylan E
    Infect Immun; 1981 Mar; 31(3):874-8. PubMed ID: 7014464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of Candida albicans mannan on development of protective immune responses in experimental murine candidiasis.
    Garner RE; Domer JE
    Infect Immun; 1994 Feb; 62(2):738-41. PubMed ID: 7507901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of mice against candidiasis.
    Jensen J; Warner T; Johnson C; Balish E
    J Infect Dis; 1996 Jul; 174(1):133-40. PubMed ID: 8655983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
    Yang YL; Wang CW; Chen CT; Wang MH; Hsiao CF; Lo HJ
    Mycol Res; 2009 Mar; 113(Pt 3):388-90. PubMed ID: 19111931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprotection against systemic candidiasis in mice.
    Tavares D; Ferreira P; Vilanova M; Videira A; Arala-Chaves M
    Int Immunol; 1995 May; 7(5):785-96. PubMed ID: 7547705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.